Investigation Report on China Rosuvastatin Market, 2010-2019
Description
First developed by Shionogi Inc. under the code name of S-4522 at the end of 1980s, rosuvastatin (rosuvastatin calcium) along with its development, marketing and sales rights, was transferred to AstraZeneca in Jun. 1998 under the code name of ZD-4522. On Nov.7, 2002, rosuvastatin got its first approval in the Netherlands and later it was approved by Health Council of Canada and FDA under the trade name of Crestor respectively in Feb. 2003 and on Aug.12, 2003. It is mainly used in the treatment of primary hypercholesterolemia, mixed lipid disorders and pure elevated triglycerides.
Ever since its marketing, rosuvastatin calcium has become a rising star of the statin class with sales value growing fast. In 2012, it even became the best-selling lipid-lowering drug around the world with a sales value of USD 6.2 billion.
Rosuvastatin develops fast after entering China, annual sales value rising from less than CNY 2 million in 2007 to CNY 672 million in 2014 and CAGR during this period reaching up to 139%. Currently, rosuvastatin in the Chinese market mainly come from the following companies: IPR Pharmaceuticals (US), Lunan Better Pharmaceutical Co., Ltd, Nanjing Chia Tai Tianqing, Simcere and Zhejiang Jingxin Pharmaceutical Co., Ltd, among which IPR Pharmaceuticals (US) has the largest market share of 82.5% for sales value in 2014.
The market size of rosuvastatin is expected to keep growing in the next few years in China.
Readers can get at least the following information from this report:
First developed by Shionogi Inc. under the code name of S-4522 at the end of 1980s, rosuvastatin (rosuvastatin calcium) along with its development, marketing and sales rights, was transferred to AstraZeneca in Jun. 1998 under the code name of ZD-4522. On Nov.7, 2002, rosuvastatin got its first approval in the Netherlands and later it was approved by Health Council of Canada and FDA under the trade name of Crestor respectively in Feb. 2003 and on Aug.12, 2003. It is mainly used in the treatment of primary hypercholesterolemia, mixed lipid disorders and pure elevated triglycerides.
Ever since its marketing, rosuvastatin calcium has become a rising star of the statin class with sales value growing fast. In 2012, it even became the best-selling lipid-lowering drug around the world with a sales value of USD 6.2 billion.
Rosuvastatin develops fast after entering China, annual sales value rising from less than CNY 2 million in 2007 to CNY 672 million in 2014 and CAGR during this period reaching up to 139%. Currently, rosuvastatin in the Chinese market mainly come from the following companies: IPR Pharmaceuticals (US), Lunan Better Pharmaceutical Co., Ltd, Nanjing Chia Tai Tianqing, Simcere and Zhejiang Jingxin Pharmaceutical Co., Ltd, among which IPR Pharmaceuticals (US) has the largest market share of 82.5% for sales value in 2014.
The market size of rosuvastatin is expected to keep growing in the next few years in China.
Readers can get at least the following information from this report:
- market size of rosuvastatin in China
- competitive landscape of rosuvastatin in Chinese market
- price of rosuvastatin made by different enterprises in China
- market outlook of rosuvastatin in China
- manufacturers of cardiovascular system drugs
- investors/ research institutions interested in Chinese medicine market
- any interest in the Chinese medicine market, please contact CRI for customized survey service
1 RELATED CONCEPTS OF ROSUVASTATIN
1.1 Indication
1.2 Sales Status in Global Market
2 MARKET PROFILE OF ROSUVASTATIN IN CHINA
2.1 Patent and Approval Status of Rosuvastatin in China
2.2 Major Manufacturers
2.3 Market Size
3 SURVEY ON SALES STATUS OF ROSUVASTATIN IN CHINA, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions
4 SURVEY ON MARKET SHARE OF MAJOR MANUFACTURERS OF ROSUVASTATIN IN CHINA, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume
5 SURVEY ON DOSAGE FORMS OF ROSUVASTATIN IN CHINA, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume
6 REFERENCE PRICE OF ROSUVASTATIN IN CHINESE HOSPITALS IN 2014
6.1 IPR Pharmaceuticals (US) (Trade Name: Crestor)
6.2 Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd. (Trade Name: Shufutan)
6.3 Nanjing Chia Tai Tianqing (Trade Name: Tuotuo)
6.4 Zhejiang Jingxin Pharmaceutical Co., Ltd (Trade Name: Jingnuo)
6.5 Lunan Better Pharmaceutical Co., Ltd (Trade Name: Ruizhi)
7 MAJOR MANUFACTURERS OF ROSUVASTATIN IN CHINESE MARKET, 2010-2014
7.1 Lunan Better Pharmaceutical Co., Ltd
7.2 Nanjing Chia Tai Tianqing
7.3 Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd.
7.4 Zhejiang Jingxin Pharmaceutical Co., Ltd
7.5 AstraZeneca plc.
8 MARKET OUTLOOK OF ROSUVASTATIN IN CHINA, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape
1.1 Indication
1.2 Sales Status in Global Market
2 MARKET PROFILE OF ROSUVASTATIN IN CHINA
2.1 Patent and Approval Status of Rosuvastatin in China
2.2 Major Manufacturers
2.3 Market Size
3 SURVEY ON SALES STATUS OF ROSUVASTATIN IN CHINA, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions
4 SURVEY ON MARKET SHARE OF MAJOR MANUFACTURERS OF ROSUVASTATIN IN CHINA, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume
5 SURVEY ON DOSAGE FORMS OF ROSUVASTATIN IN CHINA, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume
6 REFERENCE PRICE OF ROSUVASTATIN IN CHINESE HOSPITALS IN 2014
6.1 IPR Pharmaceuticals (US) (Trade Name: Crestor)
6.2 Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd. (Trade Name: Shufutan)
6.3 Nanjing Chia Tai Tianqing (Trade Name: Tuotuo)
6.4 Zhejiang Jingxin Pharmaceutical Co., Ltd (Trade Name: Jingnuo)
6.5 Lunan Better Pharmaceutical Co., Ltd (Trade Name: Ruizhi)
7 MAJOR MANUFACTURERS OF ROSUVASTATIN IN CHINESE MARKET, 2010-2014
7.1 Lunan Better Pharmaceutical Co., Ltd
7.2 Nanjing Chia Tai Tianqing
7.3 Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd.
7.4 Zhejiang Jingxin Pharmaceutical Co., Ltd
7.5 AstraZeneca plc.
8 MARKET OUTLOOK OF ROSUVASTATIN IN CHINA, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape
SELECTED CHARTS
Chart Patent Status of Rosuvastatin in China
Chart Approval Information of Rosuvastatin in China
Chart Sales Status of Rosuvastatin in China
Chart Sales Value of Rosuvastatin in China, 2010-2014
Chart Sales Value of Rosuvastatin in Some Regions in China, 2010-2014
Chart Sales Volume of Rosuvastatin in China, 2010-2014
Chart Market Share of TOP5 Manufacturers of Rosuvastatin for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Rosuvastatin Made by IPR Pharma(US) in China, 2010-2014
Chart Sales Value and Market Share of Rosuvastatin Made by Lunan Better in China, 2010-2014
Chart Sales Value and Market Share of Rosuvastatin Made by Zhejiang Jingxin in China, 2010-2014
Chart Sales Value and Market Share of Rosuvastatin Made by Nanjing Chia Tai Tianqing in China, 2010-2014
Chart Sales Value and Market Share of Rosuvastatin Made by Simcere in China, 2010-2014
Chart Sales Value and Market Share of Rosuvastatin Tablets in China, 2010-2014
Chart Sales Value and Market Share of Rosuvastatin Capsules in China, 2010-2014
Chart Price of Rosuvastatin Made by IPR Pharmaceuticals (US) in Some Chinese Cities in 2014
Chart Price of Rosuvastatin Made by Simcere in Some Chinese Cities in 2014
Chart Price of Rosuvastatin Made by Nanjing Chia Tai Tianqing in Some Chinese Cities in 2014
Chart Price of Rosuvastatin Made by Zhejiang Jingxin Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Rosuvastatin Made by Lunan Better Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Patent Status of Rosuvastatin in China
Chart Approval Information of Rosuvastatin in China
Chart Sales Status of Rosuvastatin in China
Chart Sales Value of Rosuvastatin in China, 2010-2014
Chart Sales Value of Rosuvastatin in Some Regions in China, 2010-2014
Chart Sales Volume of Rosuvastatin in China, 2010-2014
Chart Market Share of TOP5 Manufacturers of Rosuvastatin for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Rosuvastatin Made by IPR Pharma(US) in China, 2010-2014
Chart Sales Value and Market Share of Rosuvastatin Made by Lunan Better in China, 2010-2014
Chart Sales Value and Market Share of Rosuvastatin Made by Zhejiang Jingxin in China, 2010-2014
Chart Sales Value and Market Share of Rosuvastatin Made by Nanjing Chia Tai Tianqing in China, 2010-2014
Chart Sales Value and Market Share of Rosuvastatin Made by Simcere in China, 2010-2014
Chart Sales Value and Market Share of Rosuvastatin Tablets in China, 2010-2014
Chart Sales Value and Market Share of Rosuvastatin Capsules in China, 2010-2014
Chart Price of Rosuvastatin Made by IPR Pharmaceuticals (US) in Some Chinese Cities in 2014
Chart Price of Rosuvastatin Made by Simcere in Some Chinese Cities in 2014
Chart Price of Rosuvastatin Made by Nanjing Chia Tai Tianqing in Some Chinese Cities in 2014
Chart Price of Rosuvastatin Made by Zhejiang Jingxin Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Rosuvastatin Made by Lunan Better Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
